Avantor EV/EBIT AVTR

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2020.

Today, Oct 23, 2026: 30.5×
6-year median: 23.9×
Against its 6-year history: 90th; percentile: 0 is its lowest day, 100 its highest
6-year range: 10.4× to 34.2×
Peer median: 30.9×

Avantor's EV/EBIT is 30.5× as of Oct 23, 2026.

That is above its 6-year median of 23.9×, higher than on 90% of days in the last 6 years.

Over that time it ranged from 10.4× in Jan 2026 to 34.2× in Feb 2021.

The median for 10 diagnostics and research stocks of a similar size is 30.9×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	30.5×	10.4×	30.5×
2025	10.8×	10.4×	28.3×
2024	27.5×	21.1×	31.5×
2023	22.0×	17.0×	22.1×
2022	17.6×	16.5×	27.4×
2021	30.1×	27.6×	34.2×
2020	32.0×	25.0×	32.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Avantor's size, closest first, today.

Company	EV/EBIT
AVTRAvantor	30.5×
BIOBio-Rad Laboratories	40.2×
CAICaris Life Sciences	56.4×
RVTYRevvity	46.0×
MEDPMedpace	31.4×
LNTHLantheus	20.6×
LHLabcorp	21.6×
DGXQuest Diagnostics	19.5×
BLLNBillionToOne	107×
MTDMettler-Toledo International	30.5×
VCYTVeracyte	27.2×
Peer median	30.9×

Where Avantor ranks

#13of 25Diagnostics and research stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Avantor

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.